SCHEMBL31309797

SCHEMBL31309797

CC(C)(C)CCC(=O)NC(C[C@@H]1CCNC1=O)C(=O)C(=O)NC1CC1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.49
▸ CTSB P07858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24785373 0.83 CTSL (0.47) CTSLCTSB
SCHEMBL24939088 0.79 CTSV (0.51) CTSLCTSB
SCHEMBL29144560 0.78 CTSL (0.51) CTSLCTSB
SCHEMBL29144562 0.78 CTSL (0.51) CTSLCTSB
SCHEMBL29144563 0.78 CTSL (0.51) CTSLCTSB
SCHEMBL24785668 0.77 CTSL (0.48) CTSLCTSB
SCHEMBL27169741 0.76 CTSL (0.53) CTSLCTSB
SCHEMBL27169735 0.76 CTSL (0.53) CTSLCTSB
SCHEMBL29679065 0.76 CTSL (0.57) CTSLCTSB
SCHEMBL27169695 0.76 CTSL (0.57) CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263502-B1 SARS-COV-2 MPRO INHIBITOR COMPOUNDS NXERA PHARMA UK LTD (GB) 2024-12-25 — — EP claimed
Send feedback